David Egner

David Egner's work experience includes various roles in business development, strategy, and management. David is currently working at Children's Health as the Vice President of Business Development, a position they have held since April 2022. Prior to this, they worked as the Senior Director of Strategy & Business Development at Children's Health from January 2020 to March 2022 and as the Director of Strategy & Business Development from November 2017 to December 2019.

Before joining Children's Health, David worked as the Principal at Oak City Biotech Advisors from April 2017 to October 2017. David also has experience in the healthcare industry, serving as the Director of Business Development and Strategy at Bioventus from May 2012 to January 2017. In this role, they were responsible for sourcing opportunities and leading cross-functional projects related to orthobiologic therapeutics.

David's career also includes roles at Smith & Nephew, where they served as the Director of Business Development & Strategy from June 2004 to May 2012. Within Smith & Nephew, they held various positions such as Senior Business Development Manager and Director of Business Development, focusing on orthopedic trauma and biologics divisions. Prior to this, they had summer associate positions at Avondale Partners and Courage Capital Management, LLC.

In the early stages of their career, David worked as an independent consultant for various clients, including Wiland Bell Productions, John Wiley & Sons, and Yurcor. David also held marketing and content editor roles at Opus360, HealthStreet Interactive, and Reader's Digest Association.

Overall, David Egner has a strong background in business development, strategy, and healthcare, with experience in both the private sector and consulting roles.

David Egner attended Duke University from 1988 to 1992, where they obtained a Bachelor's degree in English and Economics. David later pursued an MBA at Vanderbilt University - Owen Graduate School of Management from 2002 to 2004, specializing in Finance.